a.stephanopoulos

TL3 Regular · Dresden, DE

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 29 August 2024 · last posted 2d · groups: pharmacists

130 posts, newest first. Showing up to 150.

Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #122 · Compounds › Semaglutide · 26 Jul 2026 · 0 likes Post #119 answers the question as asked. The question underneath it is different. STEP 1 and STEP 4 are two different questions. The first asks what happens when…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #54 · Compounds › Repair & healing peptides · 25 Jul 2026 · 24 likes Reading back through the absence of controlled human data threads from last year, the same three questions come up every time and only one of them has ever been…
Follow-up: How compounding permissions changed when supply normalised Replied, post #71 · Sourcing › Regulatory · 25 Jul 2026 · 10 likes I would call the community position on compounding permissions likely rather than established, and I would be comfortable defending that hedge.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #55 · Pharmacology › Receptor biology · 25 Jul 2026 · 0 likes Picking up post #52: that is the part I would want checked first. Long-term receptor changes: very little is known about what happens to receptor expression,…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #100 · Analytics › Method validation · 22 Jul 2026 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
Request: a per-category review queue Replied, post #117 · Meta › Feature requests · 20 Jul 2026 · 0 likes I have three months of notes on per-category review queue and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #94 · Analytics › Impurities & related substances · 20 Jul 2026 · 18 likes Good question, well framed, and I would like to see it answered properly.
What changed in 2026, by region — does this still hold? Replied, post #24 · Access › International · 19 Jul 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Coming back to: Telehealth prescribing models in the US Replied, post #20 · Regional › North America · 18 Jul 2026 · 22 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end. That is all the detail I have.…
Sleep quality changes during weight loss Replied, post #22 · Wellbeing › Sleep · 18 Jul 2026 · 29 likes Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them. Adding it in case it…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 12 Jul 2026 · 23 likes On post #20 — agreed on the reasoning, with one qualification. My position on four-week escalation interval is current rather than settled. I have revised it once…
Composite endpoints and the component doing the work Replied, post #6 · Evidence › Trials · 11 Jul 2026 · 9 likes Before the thread moves on from composite endpoints — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
Injection timing and sleep disruption Replied, post #3 · marked as the solution · Wellbeing › Sleep · 9 Jul 2026 · 24 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #5 · Start Here › How to Ask · 8 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
Common supplements people ask about, assessed one at a time Replied, post #2 · Practice › Interactions · 1 Jul 2026 · 0 likes This follows the opening post rather than contradicting it. Agreed on common supplements, with one qualification that I think matters. The reasoning holds for the case…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #81 · Compounds › Repair & healing peptides · 29 Jun 2026 · 28 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. I have kept the units…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Started this topic · Compounds › Repair & healing peptides · 28 Jun 2026 · 34 likes The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked…
Alcohol: what is documented and what is folklore Replied, post #76 · Practice › Interactions · 25 Jun 2026 · 2 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
Insurance and replacement policies, compared Replied, post #26 · Sourcing › Logistics · 17 Jun 2026 · 0 likes Checked the insurance and replacement policies claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #33 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 3 likes Appreciated. The plain phrasing does more work here than a longer post would.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #54 · Outcomes › Progress reports · 3 Jun 2026 · 23 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
Cold solution and stinging: the simplest fix Replied, post #29 · Practice › Administration · 27 May 2026 · 2 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
How shortages have affected compounding permissions — does this still hold? Replied, post #5 · Access › Shortages · 23 May 2026 · 4 likes I have no financial interest in anything named in this thread and I want to say so before I comment on shortages, because it is the sort of subject where it matters.
A critique that turned out to be unfair, retracted by its author Replied, post #2 · Evidence › Study critique · 22 May 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Hold a trial to the standard something could actually have met. A criticism that no achievable…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #74 · Compounds › Tirzepatide · 21 May 2026 · 24 likes Where I part company with post #70, and it is a narrow parting. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
Alcohol: what is documented and what is folklore Replied, post #21 · Practice › Interactions · 21 May 2026 · 3 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. Where a published interaction study exists it usually reports an…
How much fluid is actually needed, and how you would know Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 17 May 2026 · 15 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order.
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #10 · Evidence › Trials · 7 May 2026 · 24 likes Worth separating two things that post #6 runs together. Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing the…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #58 · Practice › Administration · 6 May 2026 · 19 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
Request: show the solution author in the topic list — what changed since Replied, post #56 · Meta › Feature requests · 3 May 2026 · 4 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
Micro-titration: a disputed topic, argued properly — one year on Replied, post #29 · Practice › Dosing & titration · 27 Apr 2026 · 7 likes Post #26 is right about the mechanism and I think understates the practical bit. On Micro-titration: the maintained page in the documentation commons covers the general…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #68 · Practice › Reconstitution · 22 Apr 2026 · 6 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Spike-and-recover accuracy for a peptide assay Replied, post #110 · Analytics › Method validation · 10 Apr 2026 · 0 likes The reason spike-and-recover accuracy keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
[2026 update] Composite endpoints and the component doing the work Replied, post #59 · Evidence › Trials · 6 Apr 2026 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Spreadsheets: an appreciation — what changed since Replied, post #9 · Lounge › Off topic · 30 Mar 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #49 · Outcomes › Body composition · 28 Mar 2026 · 22 likes Adding the measurement that post #46 says would settle it. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly…
A single out-of-range value on an otherwise normal panel Replied, post #27 · Clinical › Bloodwork · 25 Mar 2026 · 0 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading. I would want a…
The headache that turns out to be dehydration — the long version Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 24 Mar 2026 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Constipation and hydration: dehydration makes constipation worse. Increasing fluid…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #25 · Analytics › COA interpretation · 20 Mar 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #20 · Analytics › HPLC & UHPLC · 20 Mar 2026 · 0 likes This follows post #19 rather than contradicting it. Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #9 · Pharmacology › Formulation chemistry · 18 Mar 2026 · 3 likes The strongest argument against my own position on Solubility limits, stated as well as I can state it, since nobody else has yet.
Amylin receptor signalling and satiety — what changed since Replied, post #45 · Pharmacology › Receptor biology · 15 Mar 2026 · 2 likes This follows post #42 rather than contradicting it. Since Amylin receptor signalling and satiety keeps coming up, it should probably be a maintained page rather than a…
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #8 · Pharmacology › Formulation chemistry · 12 Mar 2026 · 12 likes Post #5 is the version of this I will quote in future. One addition. Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included.…
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #9 · Sourcing › Logistics · 12 Mar 2026 · 0 likes Answering the question post #7 raises rather than the one it answers. Speaking only to parcel stationary as I have actually seen it, rather than as it is usually…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #67 · Pharmacology › Pharmacokinetics · 11 Mar 2026 · 0 likes Trying to state the Washout position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Second pass at: Identical chromatograms across two different lots Replied, post #38 · Sourcing › Red flags · 2 Mar 2026 · 15 likes Picking up post #36: that is the part I would want checked first. Identical chromatograms is worth one more sentence than it usually gets, and the sentence is the one…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #134 · Access › International · 27 Feb 2026 · 0 likes On post #133 — agreed on the reasoning, with one qualification. Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting…
Preprint servers and what screening they do Replied, post #61 · Evidence › Preprints · 19 Feb 2026 · 20 likes Worth separating two things that post #59 runs together. Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more,…
Tag proliferation and whether we should prune — what changed since Replied, post #10 · Meta › Site feedback · 17 Feb 2026 · 11 likes Reporting rather than complaining: the tag filter and the category filter combine in a way I did not expect. Selecting both narrows to the intersection, which is…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #51 · Analytics › Impurities & related substances · 17 Feb 2026 · 0 likes Adding the measurement that post #48 says would settle it. The related-substances total is only as informative as the method that generated it. Two per cent by a method…
Second pass at: What pooling buys you and what it destroys Replied, post #18 · Evidence › Meta-analyses · 14 Feb 2026 · 3 likes Following this. I have the same question and no better information than the first post.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #97 · Compounds › Oral incretins · 7 Feb 2026 · 0 likes This follows post #96 rather than contradicting it. Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #4 · Analytics › Impurities & related substances · 1 Feb 2026 · 3 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #42 · Clinical › Bloodwork · 28 Jan 2026 · 11 likes The most useful thing this subcategory does is help people tell an interesting result from an uninteresting one before booking an appointment about it.
Distinguishing a red flag from an inconvenience Started this topic · Sourcing › Red flags · 15 Jan 2026 · 0 likes Distinguishing a red flag from an inconvenience — setting out what I have, and where I think it stops being reliable. Something about distinguishing a red flag does not…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #19 · Data & Tools › Calculators · 9 Jan 2026 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
Managing an unplanned gap in supply Replied, post #3 · Access › Shortages · 9 Jan 2026 · 8 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Where an alternative within the class is available, the comparison is a…
MHRA statements, read directly Replied, post #60 · Regional › UK & Ireland · 2 Jan 2026 · 14 likes Everything in post #56 holds. The case it does not cover is the one I have. Correcting an out-of-date claim in this subcategory with a source and a date is more…
Temperature loggers worth the money — the long version Replied, post #101 · Devices › Cold chain · 27 Dec 2025 · 20 likes Something worth flagging about Temperature loggers worth the money: the strongest-sounding claims in this thread are the ones with no source attached, which is the…
Aggregates and why a purity assay may miss them entirely Replied, post #29 · Analytics › Impurities & related substances · 26 Dec 2025 · 18 likes Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #21 · Pharmacology › Receptor biology · 21 Dec 2025 · 1 like Building on post #19 rather than restating it. Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal…
Second pass at: Metformin co-administration and additive GI effects Replied, post #18 · Practice › Interactions · 14 Dec 2025 · 26 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Aggregates and why a purity assay may miss them entirely Replied, post #6 · Analytics › Impurities & related substances · 12 Dec 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
[2026 update] Currency conversion and the cost you did not see Replied, post #3 · Sourcing › Payments · 5 Dec 2025 · 8 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
How the published trials escalated, tabulated side by side Started this topic · Practice › Dosing & titration · 3 Dec 2025 · 0 likes The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. Something…
Prescription requirements and telehealth models Replied, post #39 · Sourcing › Regulatory · 30 Nov 2025 · 10 likes Where I would push back on the prescription requirements and telehealth models consensus is the confidence, not the direction. The direction looks right. The confidence…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #101 · Documentation › Doc review · 27 Nov 2025 · 30 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. A weak preference rather…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #35 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. When "no data" is the complete and final answer: if there is no published human…
The anatomy of a question that gets answered within an hour — the long version Replied, post #119 · Start Here › How to Ask · 20 Nov 2025 · 28 likes Worth separating two things that post #117 runs together. Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of…
Pen dose counters: what a click does and does not guarantee Replied, post #66 · Devices › Pens & autoinjectors · 17 Nov 2025 · 1 like Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
[2026 update] What steady state means for the decision to escalate Replied, post #78 · Practice › Dosing & titration · 13 Nov 2025 · 0 likes Careful with the language on steady state. "Not detected" and "not present" are different findings and the first is a statement about the method.
Documentation that appears only after payment Replied, post #73 · Sourcing › Red flags · 10 Nov 2025 · 15 likes Picking up post #72: that is the part I would want checked first. Reporting rather than recommending, on documentation. What happened is above. Whether it should have…
Pooling trials with different estimands — what changed since Replied, post #48 · Evidence › Meta-analyses · 8 Nov 2025 · 0 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search.
Severe gastroparesis and why this class is a poor fit — one year on Started this topic · Safety › Contraindications · 5 Nov 2025 · 30 likes Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about Severe…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #87 · Practice › Reconstitution · 28 Oct 2025 · 0 likes Decimal-point error: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Publishing an inconvenient result: a case study — the long version Replied, post #11 · Sourcing › Independent verification · 16 Oct 2025 · 11 likes Post #10 is the version of this I will quote in future. One addition. The record shows what was measured. Everything beyond that is inference and this site tries to…
Where to report an adverse event officially, by region — a second dataset Replied, post #24 · Safety › Adverse events · 15 Oct 2025 · 0 likes Answering the question post #22 raises rather than the one it answers. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #106 · Compounds › Cagrilintide & amylin analogues · 6 Oct 2025 · 32 likes Everything in post #104 holds. The case it does not cover is the one I have. Cagrilintide alone is discussed less than in combination because the published data is…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #58 · Practice › Dosing & titration · 1 Oct 2025 · 10 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #19 · Compounds › Semaglutide · 26 Sep 2025 · 12 likes Building on post #16 rather than restating it. Adding a reference point for semaglutide solutions. Mine is a single case, collected without controls, and I am posting…
Reading an interaction checker output critically Replied, post #2 · Practice › Interactions · 6 Sep 2025 · 12 likes The opening post put the caveat in the right place and I want to underline it. I would rather this thread reach "we do not know" about reading an interaction checker…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #69 · Evidence › Journal club · 19 Aug 2025 · 14 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Posting it…
Publishing an inconvenient result: a case study Replied, post #52 · Sourcing › Independent verification · 20 Jul 2025 · 0 likes Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies are explained by handling or method and asking costs a day.
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #25 · Devices › Pens & autoinjectors · 19 Jul 2025 · 0 likes Building on post #24 rather than restating it. Travel with a pen raises a cold-chain question and a documentation question. The second is the one people forget until an…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #19 · Sourcing › Vendor reports · 1 Jul 2025 · 19 likes On post #15 — agreed on the reasoning, with one qualification. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #29 · Sourcing › Regulatory · 28 Jun 2025 · 2 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. Reporting rather than recommending, on Reading a regulatory notice. What happened is…
Follow-up: Requesting a page: what makes a good request Replied, post #45 · Documentation › Wiki requests · 7 Jun 2025 · 18 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. Flag a page that has drifted: if you notice a maintained page has information that…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #13 · Evidence › Trials · 4 Jun 2025 · 2 likes Nothing to add, except that this is the answer I would give if asked.
Follow-up: What other technical communities get right that we do not Replied, post #116 · Lounge › Off topic · 1 Jun 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. I would call that likely rather than…
Follow-up: What other technical communities get right that we do not Replied, post #109 · Lounge › Off topic · 25 May 2025 · 1 like Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #43 · Clinical › Comorbidities · 18 May 2025 · 17 likes I would call the community position on hepatic steatosis likely rather than established, and I would be comfortable defending that hedge.
Pregnancy as an absolute contraindication Replied, post #20 · Safety › Contraindications · 17 May 2025 · 25 likes Prior hypersensitivity to the product or its excipients is a contraindication that people forget applies to the excipients too. I have separated what I observed from…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #114 · Compounds › Cagrilintide & amylin analogues · 12 May 2025 · 0 likes Two sentences on amylin analogue mechanism and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #13 · Practice › Dosing & titration · 8 May 2025 · 2 likes Post #12 and I disagree about the size of the effect, not about the direction. Titrating on tolerability rather than on the calendar: some people escalate when they…
Reading a trial's population section before its results — does this still hold? Replied, post #80 · Evidence › Trials · 8 May 2025 · 1 like Everything in post #78 holds. The case it does not cover is the one I have. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not…
DXA precision and the least significant change for lean mass — the long version Replied, post #14 · Outcomes › Body composition · 7 May 2025 · 18 likes I would keep DXA precision and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
Micronutrient status when intake falls substantially Replied, post #2 · marked as the solution · Clinical › Bloodwork · 24 Apr 2025 · 10 likes I have been on both sides of the micronutrient status argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Coverage for the indication versus for the drug Replied, post #38 · Access › Insurance & coverage · 22 Apr 2025 · 32 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Review cadence: how often is a page actually re-checked? Replied, post #18 · Documentation › Doc review · 13 Apr 2025 · 2 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice. Noting that I have skin in…
Charge states for a 4 kDa peptide, worked through Replied, post #145 · Analytics › Mass spectrometry · 18 Mar 2025 · 17 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #23 · Sourcing › Independent verification · 4 Mar 2025 · 6 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. It is the sort of thing that…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #88 · Sourcing › Regulatory · 3 Mar 2025 · 4 likes Post #85 is right about the mechanism and I think understates the practical bit. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
Consistent declarations and why they matter more than clever ones Replied, post #71 · Sourcing › Logistics · 22 Feb 2025 · 10 likes Building on post #70 rather than restating it. Border outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent,…
SNAC and the mechanism of oral peptide absorption Replied, post #9 · Compounds › Oral incretins · 21 Feb 2025 · 25 likes This follows post #7 rather than contradicting it. Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should…
Coming back to: Official shortage notices and what they authorise Replied, post #25 · Access › Shortages · 18 Feb 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Why mass spectrometry cannot tell you about an epimer Replied, post #55 · Analytics › Mass spectrometry · 12 Feb 2025 · 0 likes Picking up post #54: that is the part I would want checked first. Resolution and mass accuracy are different specifications. An instrument can resolve two species and…
A promotion I argued against, and why I lost Replied, post #88 · Documentation › Doc review · 7 Feb 2025 · 18 likes Answering the question post #86 raises rather than the one it answers. Practical note on promotion: write down what you expect before you look. The number of times I…
Review: a draft on reconstitution arithmetic, with objections Replied, post #4 · Documentation › Doc review · 27 Jan 2025 · 21 likes Draft on reconstitution arithmetic would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Reading a supplementary appendix and finding the interesting part Replied, post #75 · Evidence › Trials · 24 Jan 2025 · 28 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #91 · Evidence › Journal club · 13 Jan 2025 · 25 likes Taking post #90 at face value and following it one step further. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #27 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 7 likes Taking post #25 at face value and following it one step further. On analysis: these are short peptides and generally straightforward chromatographically, which means a…
Follow-up: Individual participant data versus aggregate data Replied, post #65 · Evidence › Meta-analyses · 10 Jan 2025 · 11 likes Where I part company with post #63, and it is a narrow parting. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
What we do not know about retatrutide, listed explicitly Replied, post #45 · Compounds › Retatrutide · 5 Jan 2025 · 27 likes Worth separating two things that post #41 runs together. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical…
Turnaround times and what they mean for a decision — one year on Replied, post #27 · Sourcing › Independent verification · 4 Jan 2025 · 31 likes On Turnaround times: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #111 · Compounds › Oral incretins · 28 Dec 2024 · 1 like Worth separating two things that post #107 runs together. Anyone comparing published oral and injectable efficacy should check whether the comparison is within one…
[2026 update] New subcategory: rationale and scope Replied, post #59 · Meta › Announcements · 12 Dec 2024 · 0 likes This is the sort of exchange that makes the archive worth searching.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #63 · Compounds › Semaglutide · 6 Dec 2024 · 0 likes Narrowing post #62, because the general version has more than one answer. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #64 · Compounds › Tirzepatide · 1 Dec 2024 · 19 likes Adding the measurement that post #61 says would settle it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #25 · Practice › Reconstitution · 25 Nov 2024 · 9 likes What I would check first on Choosing a concentration is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #107 · Clinical › Prescriber conversations · 24 Nov 2024 · 2 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I have no interest in any supplier named above.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #33 · Access › Insurance & coverage · 19 Nov 2024 · 23 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Step therapy requirements, because it is the sort of subject…
EMA product information as a primary source — does this still hold? Replied, post #106 · Regional › European Union · 18 Nov 2024 · 28 likes Prescription status is harmonised at the level of the authorisation and the practical route to a prescription is not. Adding the caveat now so it does not have to be…
When to suspect the method rather than the sample Replied, post #26 · Analytics › Method validation · 21 Oct 2024 · 2 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Why two laboratories may disagree: after validating the same method, they may still…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #32 · Compounds › Other compounds · 4 Oct 2024 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #17 · Clinical › Comorbidities · 3 Oct 2024 · 0 likes Type 2 diabetes is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #92 · Sourcing › Independent verification · 28 Sep 2024 · 20 likes Post #90 is the version of this I will quote in future. One addition. Reading back through the Splitting a vial threads from last year, the same three questions come up…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #46 · Evidence › Journal club · 17 Sep 2024 · 6 likes The version of SURPASS-2 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
The topic list is dense — is that deliberate? Replied, post #21 · Meta › Site feedback · 3 Sep 2024 · 11 likes Topic list looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Chronic kidney disease and the FLOW result Replied, post #13 · Clinical › Comorbidities · 14 Aug 2024 · 0 likes Where I part company with post #9, and it is a narrow parting. The most useful reply I ever got about chronic kidney disease was a request to state my units. It sounds…
Spreadsheets: an appreciation Replied, post #20 · Lounge › Off topic · 8 Jun 2024 · 15 likes Small methodological point on spreadsheets: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.